Russia has given the green light for clinical trials combining a British shot from AstraZeneca Plc (AZN.L) and Oxford University with Russia's Sputnik V vaccine to go ahead, according to Russia's state drug register.
A view shows the Kremlin amid the coronavirus disease outbreak in Moscow, Russia April 20, 2020. REUTERS/Maxim Shemetov/File Photo
and Oxford University with Russia's Sputnik V vaccine to go ahead, according to Russia's state drug register. Both the AstraZeneca/Oxford and Sputnik V vaccines involve two doses - an initial shot and a booster - but Sputnik V uses different viral vectors for its two shots. "Currently, RDIF is conducting joint clinical trials to combine the first component of Sputnik V - the Sputnik Light vaccine - with vaccines from other foreign manufacturers," it said in a statement.
México Últimas Noticias, México Titulares
Similar News:También puedes leer noticias similares a ésta que hemos recopilado de otras fuentes de noticias.
Russia, Banned at the Tokyo Olympics, Is Still Trying to Be RussiaRussia is banned from the Games, but its athletes are competing as ROC—and fighting to maintain their identities without the bear symbol or national anthem
Leer más »
Russia marks Navy's 325th anniversary, Iranian ship joins inRussia has marked the 325th anniversary of the founding of its navy with ship parades at major ports.
Leer más »
Simone Biles and U.S. Teammates Stumble and Fall Behind Russia in Gymnastics QualificationsThe road to a third-straight Olympic gold medal for the Simone Biles-led U.S. women’s gymnastics team will not be the coronation everyone has been expecting
Leer más »
Gymnastics-Russia survive Asian fightback to take team goldRussia ended Asia's domination of the Olympic gymnastics men's team event on Monday when they survived a ferocious fightback from China and Japan at the Tokyo Games to claim the gold medal for the first time in 25 years.
Leer más »
Oral Covid Vaccine Set To Begin Trials In IsraelI am a London-based reporter for Forbes covering breaking news. Previously, I have worked as a reporter for a specialist legal publication covering big data and as a freelance journalist and policy analyst covering science, tech and health. I have a master’s degree in Biological Natural Sciences and a master’s degree in the History and Philosophy of Science from the University of Cambridge. Follow me on Twitter theroberthart or email me at rhartforbes.com
Leer más »
Pfizer And Moderna To Expand Studies Of Vaccines In 5- To 11-Year-OldsAt the request of the FDA, the vaccine makers are expanding their trials with young children, seeking to better detect very rare heart issues.
Leer más »